MIPS, Maryland Companies Award Faculty $3.2 Million To Develop 18 Technology-Based Products

previousPrev     Nextprevious

FOR IMMEDIATE RELEASE  February 21, 2005


Eric Schurr
301 405 3889

COLLEGE PARK, Md.—The University of Maryland’s Maryland Industrial Partnerships Program announces today it is jointly awarding $3.2 million in funding to faculty for research projects to help 17 companies in Maryland develop technology-based products.

The products include a new method for producing alternative fuel, a high-tech commuter ferry for the Chesapeake Bay, a precision weapon system, and potential treatments for cancer, brain injury, diabetes, and nerve damage.

The funding includes $1.1 million from MIPS and $2.1 million from Maryland companies. Funding goes exclusively towards the university research. Maryland faculty and students conduct the projects in close coordination with company personnel. Funding rounds occur twice yearly.

Eight of the 18 projects are in the area of biotechnology, two are in homeland security, and the remaining eight span a broad range of engineering disciplines. Six institutions in Maryland are participating, including the University of Maryland, College Park, with nine projects; the University of Maryland, Baltimore, with four projects; the University of Maryland Biotechnology Institute, with two projects; and Towson University, the University of Maryland, Eastern Shore, and the University of Maryland, Baltimore County—each with one project.

Nine of the participating companies are categorized as start-ups; eight are small, and one is medium-sized. Four are in Baltimore City, three are in Baltimore County, 10 are in Central Maryland, and 1 is in Western Maryland.

Companies project $478 million in product sales, as well as the creation of 468 high-technology jobs, if the projects are successful. MIPS funding alone provides a $2,453 job creation index based on this data, well below the $10,000 national estimate for government spending to create each new job.

Participating companies, and brief descriptions of their products, include:

  • Advanced BioNutrition Corp.—shrimp-based platform for pharmaceutical-grade protein production

  • Advanced BioNutrition Corp.—probiotic production and feed application for fish to reduce the use of antibiotics

  • Advanced Oxidation Systems, Inc.—new treatment process to eliminate volatile, organic compounds in hazardous waste using an electron beam accelerator

  • Alba Therapeutics Corp.—potential drug candidates to treat Celiac disease and new onset Type 1 diabetes

  • Archivex, Inc.—secure and long-term storage and precision dispensing system for precious biologic solutions containing DNA, cDNA, RNA, and proteins

  • Atlantic Biomass Conversions, Inc.—system to produce fuel-quality BioMethanolTM from sugar beet pulp using a new generation of the company’s direct-methanol-producing enzymes

  • Automated Precision, Inc.—algorithms and prototype software to perform 3D inspection of automobile and aerospace parts

  • BDS Dental Laboratory—clinically evaluate CAD-CAM-generated Cercon dental crowns and bridge restorations

  • Guilford Pharmaceuticals, Inc.—compounds to potentially treat acute and chronic neurodegenerative disorders

  • Maritime Applied Physics Corp.—commercial passenger hydrofoil vessel for the Chesapeake Bay

  • Neany, Inc.—low-cost, expendable, unmanned air vehicle (UAV)

  • Qovia, Inc.—extend Qovia’s capabilities to monitor and manage VoIP over wireless networks

  • Rampf Molds Industries, Inc.—integrate university-developed technologies into Rampf’s concrete molds to extend their life cycles and possibly reduce their weight

  • Rexahn Corp.—anticancer drugs targeting the proteins that maintain cell survival

  • Ruxton Pharmaceuticals, Inc.—drug to prevent morbidity and mortality in patients suffering from stroke or spinal cord injury

  • Techno-Sciences, Inc.—sensor package for weapons performance monitoring, target location, and automatic counter-fire

  • TeleContinuity, Inc.—interoperable wireless communications for first responders in and around disaster areas

  • Warner Air, LLC—active noise control system for axial fans

About MIPS
MIPS provides funding—matched by participating companies—for university-based research projects that help companies develop technology-based products. Companies with operations in Maryland are eligible, as are faculty from any of the University System of Maryland's 13 institutions. Projects must deal with innovative technological or scientific concepts and have direct commercial applications. MIPS contributes up to $100,000 for each project year; projects can be funded for one or two years. There is no limit on company project contributions. All funds go towards the university research. Reported company matching funds include both cash and in-kind contributions, such as salaries and wages, materials and equipment, travel and other expenses budgeted for projects.

MIPS is a program of the A. James Clark School of Engineering’s Maryland Technology Enterprise Institute (MTECH), whose mission is to enable technology commercialization, strengthen companies, and catalyze new ventures in Maryland.

Complete listing of Round 35 project awards.



Sign Up For Updates